Titre : Vaccins atténués

Vaccins atténués : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment savoir si un vaccin est atténué ?

Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents.
Vaccins atténués Agents pathogènes Immunisation
#2

Quels tests pour vérifier l'efficacité d'un vaccin atténué ?

Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination.
Tests sérologiques Efficacité des vaccins Immunité

Symptômes 2

#1

Quels symptômes peuvent apparaître après un vaccin atténué ?

Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir.
Réactions aux vaccins Effets secondaires Fièvre
#2

Les vaccins atténués causent-ils des maladies ?

Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée.
Maladies infectieuses Réactions indésirables Vaccins

Prévention 2

#1

Comment se préparer avant de recevoir un vaccin atténué ?

Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination.
Préparation à la vaccination Antécédents médicaux Vaccins
#2

Les vaccins atténués sont-ils sûrs pour tous ?

Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées.
Immunodépression Sécurité des vaccins Vaccins atténués

Traitements 2

#1

Que faire en cas de réaction sévère à un vaccin atténué ?

Consulter immédiatement un professionnel de santé pour évaluer la situation.
Réactions allergiques Traitement médical Vaccins
#2

Les vaccins atténués nécessitent-ils un traitement préventif ?

Non, mais des antécédents médicaux doivent être évalués avant la vaccination.
Antécédents médicaux Prévention Vaccins

Complications 2

#1

Quelles complications peuvent survenir avec un vaccin atténué ?

Des complications rares incluent des infections chez les personnes immunodéprimées.
Complications Infections Vaccins atténués
#2

Les complications des vaccins atténués sont-elles fréquentes ?

Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance.
Surveillance médicale Effets indésirables Vaccins

Facteurs de risque 2

#1

Qui devrait éviter les vaccins atténués ?

Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins.
Immunodépression Grossesse Vaccins atténués
#2

Les antécédents d'allergies influencent-ils la vaccination ?

Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable.
Allergies Évaluation médicale Vaccins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins atténués : Questions médicales les plus fréquentes", "headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-19", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins atténués" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins", "url": "https://questionsmedicales.fr/mesh/D014612", "about": { "@type": "MedicalCondition", "name": "Vaccins", "code": { "@type": "MedicalCode", "code": "D014612", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894" } } }, "about": { "@type": "MedicalCondition", "name": "Vaccins atténués", "alternateName": "Vaccines, Attenuated", "code": { "@type": "MedicalCode", "code": "D014613", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Aitor Nogales", "url": "https://questionsmedicales.fr/author/Aitor%20Nogales", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com." } }, { "@type": "Person", "name": "Charles Grose", "url": "https://questionsmedicales.fr/author/Charles%20Grose", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA." } }, { "@type": "Person", "name": "Manish Patel", "url": "https://questionsmedicales.fr/author/Manish%20Patel", "affiliation": { "@type": "Organization", "name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov." } }, { "@type": "Person", "name": "Jessie R Chung", "url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung", "affiliation": { "@type": "Organization", "name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study of infections caused by", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35967868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2022.867347" } }, { "@type": "ScholarlyArticle", "name": "Errors in Surgery: A Case Control Study.", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35946794", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SLA.0000000000005664" } }, { "@type": "ScholarlyArticle", "name": "Iron status in women with infertility and controls: a case-control study.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37361544", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1173100" } }, { "@type": "ScholarlyArticle", "name": "Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35788952", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11695-022-06193-8" } }, { "@type": "ScholarlyArticle", "name": "Diverticulitis Familiality: A Statewide Case-Control Study.", "datePublished": "2023-07-05", "url": "https://questionsmedicales.fr/article/37403933", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/XCS.0000000000000799" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins atténués", "item": "https://questionsmedicales.fr/mesh/D014613" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins atténués - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins atténués", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins atténués", "description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Case-Control+Studies#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins atténués", "description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Case-Control+Studies#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins atténués", "description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Case-Control+Studies#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins atténués", "description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Case-Control+Studies#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins atténués", "description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Case-Control+Studies#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins atténués", "description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Case-Control+Studies#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment savoir si un vaccin est atténué ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents." } }, { "@type": "Question", "name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination." } }, { "@type": "Question", "name": "Quels symptômes peuvent apparaître après un vaccin atténué ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir." } }, { "@type": "Question", "name": "Les vaccins atténués causent-ils des maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée." } }, { "@type": "Question", "name": "Comment se préparer avant de recevoir un vaccin atténué ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination." } }, { "@type": "Question", "name": "Les vaccins atténués sont-ils sûrs pour tous ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées." } }, { "@type": "Question", "name": "Que faire en cas de réaction sévère à un vaccin atténué ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Consulter immédiatement un professionnel de santé pour évaluer la situation." } }, { "@type": "Question", "name": "Les vaccins atténués nécessitent-ils un traitement préventif ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un vaccin atténué ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des infections chez les personnes immunodéprimées." } }, { "@type": "Question", "name": "Les complications des vaccins atténués sont-elles fréquentes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance." } }, { "@type": "Question", "name": "Qui devrait éviter les vaccins atténués ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins." } }, { "@type": "Question", "name": "Les antécédents d'allergies influencent-ils la vaccination ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 13/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

None None

3 publications dans cette catégorie

Publications dans "Vaccins atténués" :

Aitor Nogales

3 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.

Charles Grose

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.

Manish Patel

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.

Jessie R Chung

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.

Brendan Flannery

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.

Ashley L Fowlkes

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :

Alicia M Fry

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :

James Weger-Lucarelli

2 publications dans cette catégorie

Affiliations :
  • Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
  • Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.

Anne A Gershon

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Michael D Gershon

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Pilar Blanco-Lobo

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.

Luis Martínez-Sobrido

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.

Stephen Higgs

2 publications dans cette catégorie

Affiliations :
  • Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.

Laura Rodriguez

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
  • Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.

Michael E Smith

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States.

Kayan Dunnigan

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States.

Manjusha Gaglani

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.

Mark G Thompson

2 publications dans cette catégorie

Affiliations :
  • U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.

Luis Martinez-Sobrido

2 publications dans cette catégorie

Affiliations :
  • Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.

Sources (10000 au total)

A case-control study of infections caused by

Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 prod... A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patie... One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days wer... In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infe...

Errors in Surgery: A Case Control Study.

While errors can harm patients they remain poorly studied. This study characterized errors in the care of surgical patients and examined the association of errors with morbidity and mortality.... Errors have been reported to cause <10% or >60% of adverse events. Such discordant results underscore the need for further exploration of the relationship between error and adverse events.... Patients with operations performed at a single institution and abstracted into the American College of Surgeons National Surgical Quality Improvement Program from January 1, 2018, to December 31, 2018... Of 1899 patients, 170 were defined as cases who experienced a morbidity or mortality. The majority of cases (n=93; 55%) had at least 1 error; of the 329 matched control patients, 112 had at least 1 er... Errors in surgical care were associated with postoperative morbidity. Reducing errors requires measurement of errors....

Iron status in women with infertility and controls: a case-control study.

Iron deficiency is a common problem in subfertile women. The influence of iron status on unexplained infertility is unknown.... In a case-control study, 36 women with unexplained infertility and 36 healthy non-infertile controls were included. Parameters of iron status including serum ferritin and a serum ferritin <30 µg/dL se... Women with unexplained infertility demonstrated a lower transferrin saturation (median 17.3%, IQR 12.7-25.2 versus 23.9%, IQR 15.4-31.6;... Ferritin levels <30µg/L were associated with unexplained infertility and might be screened in the future. Further studies with a focus on iron deficiency and iron treatment on women with unexplained i...

Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.

There are few studies published referring to bariatric surgery in patients older than 70 years. The aim of this study is to evaluate whether there are benefits to performing sleeve gastrectomy (SG) in... Data were retrospectively collected from a Private Clinic's electronic medical records of patients undergoing SG between June 2017 and September 2020. Inclusion criteria were patients older than 70 ye... Fifty patients were included in the study. Both groups were similar regarding gender, weight, BMI, and presence of DM. The 30-day morbidity and mortality were similar between the groups. The patients ... The sleeve gastrectomy surgery performed in patients over 70 years of age is safe. The early results suggest similar benefits regarding weight loss and improvement of comorbidities to those having SG ...

Diverticulitis Familiality: A Statewide Case-Control Study.

The etiology of diverticulitis is multifactorial and poorly understood. We estimated the familiality of diverticulitis using the Utah Population Database, a statewide database linking medical records ... We identified patients with diverticulitis diagnosed between 1998 and 2018 and age- and sex-matched controls in the Utah Population Database. Risk of diverticulitis in family members of patients and c... The study population included 9,563 diverticulitis patients (with 229,647 relatives) and 10,588 controls (with 265,693 relatives). Relatives of patients were more likely to develop diverticulitis (inc... Our results indicate that the first-, second-, and third-degree relatives of diverticulitis patients are at elevated risk of developing diverticulitis. This information may aid surgeons in counseling ...

Thrombocytosis in patients with spondyloarthritis: a case-control study.

This study aimed to investigate the clinical and laboratory as well as radiological features of spondyloarthritis (SpA) patients with thrombocytosis and to explore risk factor for thrombocytosis in Sp... A total of 145 patients with SpA were included in this study, and non-thrombocytosis was identified in 76 patients while thrombocytosis was found in 69 patients, 38 out of the 69 patients received ant... The proportion of hip involvement (60.86% vs 36.84%, p = 0.004), bath ankylosing spondylitis disease activity index score (4.24 ± 0.55 vs 3.69 ± 0.67, p < 0.001), erythrocyte sedimentation rate (62.22... SpA patients with thrombocytosis have a higher proportion of hip involvement and disease activity compared to non-thrombocytosis SpA patients. The potential risk factors for thrombocytosis in SPA pati...

Vestibulodynia and the Vaginal Microbiome: A Case-Control Study.

Recent studies of the vaginal microbiome have led to a better understanding of the microbiota and interactions with the host environment, however the role of the vaginal microbiome in vestibulodynia r... This study aims to investigate and examine differences in the bacterial and fungal microbiome among patients with vestibulodynia and healthy controls.... A case-control study was conducted examining the vaginal microbiome of 29 patients with vestibulodynia and 26 controls through Stony Brook University Obstetrics and Gynecology ambulatory clinic. Exclu... Principal component analysis (PCA) and linear discriminant analysis effect size (LefSe) were used to identify differences in relative abundance of operational taxonomic units (OTUs) for the vaginal mi... Lactobacillus species were dominant amongst both cases and controls. PCA of 16S and ITS OTUs did not show significant differences in microbiome composition between vestibulodynia patients and controls... Additional studies are needed to further assess the clinical significance of these findings.... Strengths of this study include ITS amplicon sequence analysis for fungal species diversity. Limitations of this study include small sample size and lack of racial diversity.... Our study did not find significant differences in composition or diversity between the vaginal microbiomes of cases of vestibulodynia and controls; however, the data suggests differences in abundance ...

Bladder cancer with pioglitazone: A case-control study.

Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes.... To study an association (prevalence and predictors) of bladder malignancy with pioglitazone therapy in Asian-Indian type 2 diabetes patients.... In this observational multicenter study, type 2 diabetic patients attending out-patient diabetes-clinic were evaluated. A detailed history of anti-diabetic medication, dose, duration, pioglitazone usa... A total of 8000 patients were screened out of which 1560 were excluded. Among 6440 included patients, 1056 (16.3%) patients were in group A and 5384 (83.6%) group B. Patients on pioglitazone were olde... Pioglitazone use in Asian-Indians is not associated with an increased bladder cancer risk. However, pioglitazone should be restricted in individuals with history of hematuria. Age more than 58 years i...

HTRA1 methylation in peripheral blood as a potential marker for the preclinical detection of stroke: a case-control study and a prospective nested case-control study.

Stroke is the leading cause of mortality in China. DNA methylation has essential roles in multiple diseases, but its association with stroke was barely studied. We hereby explored the association betw... The association was discovered in a hospital-based case-control study (cases/controls = 190:190) and further validated in a prospective nested case-control study including 139 cases who developed stro... In our study, altered HTRA1 methylation was associated with stroke at clinical and preclinical stages and thus may provide a potential biomarker in the blood for the risk evaluation and preclinical de...